ORGO (STOCKS)
Organogenesis Holdings Inc. Class A Common Stock
$2.350000
-0.030000 (-1.26%)
Prev close: $2.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Gary S. Gillheeney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $305.52M
- Employees
- 869
- P/E (TTM)
- 15.48
- P/B (TTM)
- 1.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $564.17M |
| Benefits Costs and Expenses | $517.20M |
| Costs And Expenses | $517.20M |
| Nonoperating Income/Loss | $2.28M |
| Operating Expenses | $519.48M |
| Selling, General, and Administrative Expenses | $326.24M |
| Research and Development | $44.54M |
| Other Operating Expenses | $148.70M |
| Operating Income/Loss | $44.69M |
| Income/Loss From Continuing Operations After Tax | $37.03M |
| Income/Loss From Continuing Operations Before Tax | $46.97M |
| Income Tax Expense/Benefit | $9.94M |
| Income Tax Expense/Benefit, Current | $438.00K |
| Income Tax Expense/Benefit, Deferred | $9.50M |
| Net Income/Loss | $37.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $37.03M |
| Net Income/Loss Available To Common Stockholders, Basic | $20.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $17.01M |
| Preferred Stock Dividends And Other Adjustments | $17.01M |
| Basic Earnings Per Share | $0.16 |
| Diluted Earnings Per Share | $0.15 |
| Basic Average Shares | 126,738,136 |
| Diluted Average Shares | 130,248,412 |
| Assets | $598.73M |
| Current Assets | $362.19M |
| Inventory | $29.63M |
| Prepaid Expenses | $18.35M |
| Other Current Assets | $314.21M |
| Noncurrent Assets | $236.54M |
| Fixed Assets | $103.71M |
| Intangible Assets | $9.15M |
| Other Non-current Assets | $123.69M |
| Liabilities | $164.81M |
| Current Liabilities | $100.12M |
| Accounts Payable | $31.95M |
| Wages | $42.71M |
| Other Current Liabilities | $25.46M |
| Noncurrent Liabilities | $64.69M |
| Equity | $300.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $300.13M |
| Temporary Equity | $133.79M |
| Temporary Equity Attributable To Parent | $133.79M |
| Liabilities And Equity | $598.73M |
| Net Cash Flow From Operating Activities | -$10.31M |
| Net Cash Flow From Operating Activities, Continuing | -$10.31M |
| Net Cash Flow From Investing Activities | -$14.15M |
| Net Cash Flow From Investing Activities, Continuing | -$14.15M |
| Net Cash Flow From Financing Activities | -$17.36M |
| Net Cash Flow From Financing Activities, Continuing | -$17.36M |
| Net Cash Flow | -$41.82M |
| Net Cash Flow, Continuing | -$41.82M |
| Comprehensive Income/Loss | $37.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $37.03M |
| Other Comprehensive Income/Loss | $0.00 |